Cho, E., Han, K., Kim, B., & Lee, D. H. (2020). Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus. Medicine (Baltimore).
Chicago Style aipamenaCho, Eun-Hee, Kyungdo Han, Bongseong Kim, and Dae Ho Lee. "Gliclazide Monotherapy Increases Risks of All-cause Mortality and Has Similar Risk of Acute Myocardial Infarction and Stroke With Glimepiride Monotherapy in Korean Type 2 Diabetes Mellitus." Medicine (Baltimore) 2020.
MLA aipamenaCho, Eun-Hee, Kyungdo Han, Bongseong Kim, and Dae Ho Lee. "Gliclazide Monotherapy Increases Risks of All-cause Mortality and Has Similar Risk of Acute Myocardial Infarction and Stroke With Glimepiride Monotherapy in Korean Type 2 Diabetes Mellitus." Medicine (Baltimore) 2020.